文献速递临床试验与 GCP

弯针房角切开术与房角镜辅助经腔内小梁切开术治疗原发性开角型青光眼:随机临床试验研究方案

Bent ab interno needle goniotomy versus gonioscopy-assisted transluminal trabeculotomy in primary open-angle glaucoma: study protocol of a randomized clinical trial.
PubMed 文献 · Trials · 2024-05-03

这是一项平行双组单盲随机临床试验方案,纳入已行白内障摘除的原发性开角型青光眼眼,比较弯针房角切开术(BANG)与房角镜辅助经腔内小梁切开术(GATT)的长期眼压控制与安全性,主要结局为术后眼压下降。

要点

  • 方案比较BANG与GATT两种低成本微创青光眼手术的长期眼压控制与安全性。
  • 纳入已行白内障摘除的原发性开角型青光眼眼,术后随访至360天。
  • 主要结局为术后眼压下降,并在30、90、180、360天评估功能、结构、安全与生活质量。

核心结论

  • 本方案旨在比较两种低成本微创青光眼手术BANG与GATT的长期疗效与安全性。
  • 已有文献多为病例系列或回顾性研究且方案不一、纳入不同青光眼类型与严重度并联合白内障摘除;本方案仅纳入轻中度原发性开角型青光眼且此前白内障摘除成功眼。
  • 方案提供可复制的标准化流程,便于未来研究比较不同微创青光眼手术技术的疗效、安全性与患者生活质量。

研究设计与样本

  • 平行双组单盲随机临床试验方案,纳入已行白内障摘除的原发性开角型青光眼眼。
  • 符合纳入标准后先洗脱药物以核实基线眼压,再用密封信封随机分配至BANG或GATT。
  • 术后随访时间为1、7、15、30、60、90、180、330和360天,术后330天再次进行药物洗脱。
  • 主要结局为术后眼压下降,并在30、90、180、360天补充评估功能与结构参数、安全性与生活质量。
  • 试验在巴西临床试验注册平台(ReBEC)回顾性注册,注册号RBR-268ms5y,注册日期2023年7月29日;研究获坎皮纳斯大学伦理委员会批准。

局限性

  • 原文在讨论中未报告本研究方案的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive glaucoma surgery (MIGS) is a new class of surgeries, which combines moderate to high success rates and a high safety profile. Bent Ab interno Needle Goniotomy (BANG) and Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) are two low-cost MIGS procedures that communicate the anterior chamber to Schlemm's canal. Most of the available publications on MIGS are either case series or retrospective studies, with different study protocols. The aim of this manuscript is to describe a randomized clinical trial (RCT) protocol to compare the long-term intraocular pressure (IOP) control and the safety of both procedures in eyes with primary open-angle glaucoma. METHODS: This is a parallel, double-arm, single-masked RCT that includes pseudophakic primary open-angle glaucoma (POAG) eyes. After inclusion criteria, medications will be washed out to verify baseline IOP before surgery. Patients will be randomized to BANG or GATT using a sealed envelope. Follow-up visits will be 1, 7, 15, 30, 60, 90, 180, 330 and 360 days after surgery. On PO330, a new medication washout will be done. The main outcome is the IOP reduction following the procedures. Complimentary evaluation of functional and structural parameters, safety, and quality of life will be done after 30, 90, 180, and 360 days. DISCUSSION: Our study was designed to compare the long-term efficacy and safety of two low-cost MIGS. Most of the published studies on this subject are case series or retrospective cohorts, with different study protocols, which included different types and severities of glaucomas, combined with cataract extraction. Our study only included mild to moderate POAG eyes, with previous successful cataract extraction. Moreover, it provides a standardized protocol that could be replicated in future studies investigating various types of MIGS. This would allow comparison between different techniques in terms of efficacy, safety, and patients' quality of life. TRIAL REGISTRATION: Retrospectively registered at the Registro Brasileiro de Ensaios Clínicos (ReBEC) platform RBR-268ms5y . Registered on July 29, 2023. The study was approved by the Ethics Committee of the University of Campinas, Brazil.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ayub G, De Francesco T, Costa VP, et al. Bent ab interno needle goniotomy versus gonioscopy-assisted transluminal trabeculotomy in primary open-angle glaucoma: study protocol of a randomized clinical trial. Trials. 2024. PMID: 38702810. doi:10.1186/s13063-024-08134-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。